HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

dichlorotetrakis(dimethyl sulfoxide)ruthenium II (trans-Ru)

RN given refers to parent cpd without isomeric designation,
Also Known As:
trans-Ru; RuCl2(DMSO)4; cis-RuCl2(DMSO)4; cis-dichlorotetrakis(dimethyl sulfoxide)ruthenium II; dichlorotetrakis(dimethyl sulfoxide)ruthenium II, (S)-(OC-6-22)-isomer; trans-RuCl2(DMSO)4
Networked: 9 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Tfouni, Elia: 2 articles (10/2013 - 04/2008)
2. Espreafico, Enilza M: 2 articles (10/2013 - 04/2008)
3. Gomes, Anderson J: 2 articles (10/2013 - 04/2008)
4. Sorc, A: 2 articles (12/2000 - 09/2000)
5. Sava, G: 2 articles (12/2000 - 09/2000)
6. Iengo, E: 2 articles (12/2000 - 09/2000)
7. Bergamo, A: 2 articles (12/2000 - 09/2000)
8. Alessio, E: 2 articles (12/2000 - 09/2000)
9. Gava, B: 2 articles (12/2000 - 09/2000)
10. Zorzet, S: 2 articles (12/2000 - 09/2000)

Related Diseases

1. Neoplasms (Cancer)
2. Carcinoma (Carcinomatosis)
3. Adenocarcinoma
4. Melanoma (Melanoma, Malignant)
5. Lewis Lung Carcinoma

Related Drugs and Biologics

1. imidazolium- bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III) (NAMI-A)
2. Plastics
3. Ruthenium
4. Nitric Oxide (Nitrogen Monoxide)
5. polylactic acid-polyglycolic acid copolymer (PLGA)
6. 6-Mercaptopurine (Mercaptopurine)
7. Sodium
8. Cisplatin (Platino)
9. matrigel
10. imidazole